Trial Outcomes & Findings for Transcranial Electrostimulation and Obstructive Sleep Apnea Surgery (NCT NCT03735004)

NCT ID: NCT03735004

Last Updated: 2026-06-22

Results Overview

IV morphine milligram equivalents

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

45 participants

Primary outcome timeframe

Recorded during a 20 min TES session administered for first moderate-to-severe postoperative pain in the recovery room

Results posted on

2026-06-22

Participant Flow

Participant milestones

Participant milestones
Measure
TES 60 Hz DC:AC
Transcranial electrostimulation (TES) with combined direct (DC) and alternating (AC, 60 Hz) current
TES 100 Hz DC:AC
Transcranial electrostimulation (TES) with combined direct (DC) and alternating (AC, 100 Hz) current
TES With DC Current
Transcranial electrostimulation (TES) with direct current (DC) only
Overall Study
STARTED
15
15
15
Overall Study
COMPLETED
15
15
15
Overall Study
NOT COMPLETED
0
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
TES 60 Hz DC:AC
n=15 Participants
Transcranial electrostimulation (TES) with combined direct (DC) and alternating (AC, 60 Hz) current
TES 100 Hz DC:AC
n=15 Participants
Transcranial electrostimulation (TES) with combined direct (DC) and alternating (AC, 100 Hz) current
TES With DC Current
n=15 Participants
Transcranial electrostimulation (TES) with direct current (DC) only
Total
n=45 Participants
Total of all reporting groups
Age, Continuous
50.7 years
STANDARD_DEVIATION 12.3 • n=15 Participants
41.5 years
STANDARD_DEVIATION 11.5 • n=15 Participants
46.7 years
STANDARD_DEVIATION 10.3 • n=15 Participants
46.3 years
STANDARD_DEVIATION 11.7 • n=45 Participants
Sex: Female, Male
Female
5 Participants
n=15 Participants
2 Participants
n=15 Participants
2 Participants
n=15 Participants
9 Participants
n=45 Participants
Sex: Female, Male
Male
10 Participants
n=15 Participants
13 Participants
n=15 Participants
13 Participants
n=15 Participants
36 Participants
n=45 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
Region of Enrollment
United States
15 Participants
n=15 Participants
15 Participants
n=15 Participants
15 Participants
n=15 Participants
45 Participants
n=45 Participants
Height
170.5 cm
STANDARD_DEVIATION 10.5 • n=15 Participants
176.3 cm
STANDARD_DEVIATION 10.4 • n=15 Participants
178.7 cm
STANDARD_DEVIATION 8.6 • n=15 Participants
175.2 cm
STANDARD_DEVIATION 10.3 • n=45 Participants
Weight
92.3 kg
STANDARD_DEVIATION 17.1 • n=15 Participants
92.5 kg
STANDARD_DEVIATION 19.9 • n=15 Participants
97.7 kg
STANDARD_DEVIATION 14.9 • n=15 Participants
94.2 kg
STANDARD_DEVIATION 17.2 • n=45 Participants
Body Mass Index (BMI)
31.4 kg/m^2
STANDARD_DEVIATION 5.4 • n=15 Participants
30.0 kg/m^2
STANDARD_DEVIATION 7.0 • n=15 Participants
30.6 kg/m^2
STANDARD_DEVIATION 4.5 • n=15 Participants
30.6 kg/m^2
STANDARD_DEVIATION 5.5 • n=45 Participants
American Society of Anesthesiologists (ASA) class
Class 1
0 Participants
n=15 Participants
0 Participants
n=15 Participants
0 Participants
n=15 Participants
0 Participants
n=45 Participants
American Society of Anesthesiologists (ASA) class
Class 2
4 Participants
n=15 Participants
4 Participants
n=15 Participants
5 Participants
n=15 Participants
13 Participants
n=45 Participants
American Society of Anesthesiologists (ASA) class
Class 3
11 Participants
n=15 Participants
11 Participants
n=15 Participants
10 Participants
n=15 Participants
32 Participants
n=45 Participants
Apnea-Hypopnea Index
48.3 events per hour
STANDARD_DEVIATION 23.4 • n=15 Participants
42.1 events per hour
STANDARD_DEVIATION 20.3 • n=15 Participants
46.7 events per hour
STANDARD_DEVIATION 28.6 • n=15 Participants
45.7 events per hour
STANDARD_DEVIATION 23.9 • n=45 Participants

PRIMARY outcome

Timeframe: Recorded during a 20 min TES session administered for first moderate-to-severe postoperative pain in the recovery room

IV morphine milligram equivalents

Outcome measures

Outcome measures
Measure
TES 100 Hz DC:AC
n=15 Participants
Transcranial electrostimulation (TES) with combined direct (DC) and alternating (AC, 100 Hz) current
TES With DC Current
n=15 Participants
Transcranial electrostimulation (TES) with direct current (DC) only
TES 60 Hz DC:AC
n=15 Participants
Transcranial electrostimulation (TES) with combined direct (DC) and alternating (AC, 60 Hz) current
Opioid Requirements During First Postoperative TES Session
6.9 IV morphine milligram equivalents
Standard Deviation 5.5
9.8 IV morphine milligram equivalents
Standard Deviation 3.8
3.3 IV morphine milligram equivalents
Standard Deviation 4.5

PRIMARY outcome

Timeframe: Recorded during a 20 min TES session administered for first moderate-to-severe postoperative pain in the recovery room

Population: Participants with available data

VAS pain scores (Pain measured using 11-point visual analog scale 0-10, 0 no pain, 10 worst pain imaginable).

Outcome measures

Outcome measures
Measure
TES 100 Hz DC:AC
n=14 Participants
Transcranial electrostimulation (TES) with combined direct (DC) and alternating (AC, 100 Hz) current
TES With DC Current
n=15 Participants
Transcranial electrostimulation (TES) with direct current (DC) only
TES 60 Hz DC:AC
n=15 Participants
Transcranial electrostimulation (TES) with combined direct (DC) and alternating (AC, 60 Hz) current
Pain Scores During First Postoperative TES Session
7.2 score on a scale
Standard Deviation 1.6
7.8 score on a scale
Standard Deviation 1.5
6.6 score on a scale
Standard Deviation 1.8

PRIMARY outcome

Timeframe: During the recovery room stay until "floor ready" (on average 2.5 hours)

IV morphine milligram equivalents

Outcome measures

Outcome measures
Measure
TES 100 Hz DC:AC
n=15 Participants
Transcranial electrostimulation (TES) with combined direct (DC) and alternating (AC, 100 Hz) current
TES With DC Current
n=15 Participants
Transcranial electrostimulation (TES) with direct current (DC) only
TES 60 Hz DC:AC
n=15 Participants
Transcranial electrostimulation (TES) with combined direct (DC) and alternating (AC, 60 Hz) current
Postoperative Opioid Consumption During Recovery Room Stay
19.10 IV morphine milligram equivalents
Standard Deviation 12.97
25.22 IV morphine milligram equivalents
Standard Deviation 11.71
10.62 IV morphine milligram equivalents
Standard Deviation 9.5

PRIMARY outcome

Timeframe: During the recovery room stay until "floor ready" (on average 2.5 hours)

VAS pain scores (Pain measured using 11-point visual analog scale 0-10, 0 no pain, 10 worst pain imaginable).

Outcome measures

Outcome measures
Measure
TES 100 Hz DC:AC
n=15 Participants
Transcranial electrostimulation (TES) with combined direct (DC) and alternating (AC, 100 Hz) current
TES With DC Current
n=15 Participants
Transcranial electrostimulation (TES) with direct current (DC) only
TES 60 Hz DC:AC
n=15 Participants
Transcranial electrostimulation (TES) with combined direct (DC) and alternating (AC, 60 Hz) current
Postoperative Pain Scores During Recovery Room Stay
5.8 score on a scale
Standard Deviation 1.5
6.5 score on a scale
Standard Deviation 1.3
5.4 score on a scale
Standard Deviation 0.9

SECONDARY outcome

Timeframe: From "floor ready" until midnight of the day after surgery (POD#0, (postoperative day #0).

PO morphine milligram equivalents

Outcome measures

Outcome measures
Measure
TES 100 Hz DC:AC
n=15 Participants
Transcranial electrostimulation (TES) with combined direct (DC) and alternating (AC, 100 Hz) current
TES With DC Current
n=15 Participants
Transcranial electrostimulation (TES) with direct current (DC) only
TES 60 Hz DC:AC
n=15 Participants
Transcranial electrostimulation (TES) with combined direct (DC) and alternating (AC, 60 Hz) current
Postoperative Opioid Consumption During Post-operative Day 0
19.9 oral morphine milligram equivalents
Standard Deviation 17.9
25.1 oral morphine milligram equivalents
Standard Deviation 12.0
27.1 oral morphine milligram equivalents
Standard Deviation 20.1

SECONDARY outcome

Timeframe: From POD#1 through the 1st postoperative week after surgery.

Population: Participants with available data

PO morphine milligram equivalents

Outcome measures

Outcome measures
Measure
TES 100 Hz DC:AC
n=14 Participants
Transcranial electrostimulation (TES) with combined direct (DC) and alternating (AC, 100 Hz) current
TES With DC Current
n=15 Participants
Transcranial electrostimulation (TES) with direct current (DC) only
TES 60 Hz DC:AC
n=15 Participants
Transcranial electrostimulation (TES) with combined direct (DC) and alternating (AC, 60 Hz) current
Post-discharge Postoperative Opioid Consumption
249.0 oral morphine milligram equivalents
Standard Deviation 237.8
343.1 oral morphine milligram equivalents
Standard Deviation 154.2
250 oral morphine milligram equivalents
Standard Deviation 138.3

SECONDARY outcome

Timeframe: Day of surgery (postoperative day #0, POD#0).

Outcome measures

Outcome measures
Measure
TES 100 Hz DC:AC
n=15 Participants
Transcranial electrostimulation (TES) with combined direct (DC) and alternating (AC, 100 Hz) current
TES With DC Current
n=15 Participants
Transcranial electrostimulation (TES) with direct current (DC) only
TES 60 Hz DC:AC
n=15 Participants
Transcranial electrostimulation (TES) with combined direct (DC) and alternating (AC, 60 Hz) current
Time to Discharge From the Recovery Room
129.3 minutes
Interval 105.4 to 155.9
133.2 minutes
Interval 108.7 to 156.9
82.7 minutes
Interval 72.5 to 94.1

SECONDARY outcome

Timeframe: Day of surgery to starting a soft diet (up to 7 days postoperative)

Population: Participants with available data

Outcome measures

Outcome measures
Measure
TES 100 Hz DC:AC
n=12 Participants
Transcranial electrostimulation (TES) with combined direct (DC) and alternating (AC, 100 Hz) current
TES With DC Current
n=14 Participants
Transcranial electrostimulation (TES) with direct current (DC) only
TES 60 Hz DC:AC
n=15 Participants
Transcranial electrostimulation (TES) with combined direct (DC) and alternating (AC, 60 Hz) current
Time to Start of Soft Diet
4.7 days
Standard Deviation 4.5
5.1 days
Standard Deviation 5.2
3.5 days
Standard Deviation 2.9

SECONDARY outcome

Timeframe: Day of surgery to return to daily activities to postoperative week 4.

Population: Participants with available data

Outcome measures

Outcome measures
Measure
TES 100 Hz DC:AC
n=10 Participants
Transcranial electrostimulation (TES) with combined direct (DC) and alternating (AC, 100 Hz) current
TES With DC Current
n=14 Participants
Transcranial electrostimulation (TES) with direct current (DC) only
TES 60 Hz DC:AC
n=15 Participants
Transcranial electrostimulation (TES) with combined direct (DC) and alternating (AC, 60 Hz) current
Time to Return to Daily Activities
13 days
Standard Deviation 4.6
12.9 days
Standard Deviation 6.7
11.2 days
Standard Deviation 6.8

SECONDARY outcome

Timeframe: From the day of surgery to return to work to postoperative week 4.

Population: Participants with available data

Outcome measures

Outcome measures
Measure
TES 100 Hz DC:AC
n=13 Participants
Transcranial electrostimulation (TES) with combined direct (DC) and alternating (AC, 100 Hz) current
TES With DC Current
n=14 Participants
Transcranial electrostimulation (TES) with direct current (DC) only
TES 60 Hz DC:AC
n=14 Participants
Transcranial electrostimulation (TES) with combined direct (DC) and alternating (AC, 60 Hz) current
Time to Return to Work
18.5 days
Standard Deviation 7.9
18.6 days
Standard Deviation 8.6
16.5 days
Standard Deviation 9.6

SECONDARY outcome

Timeframe: Baseline (before surgery) to postoperative week 4.

Population: Participants with available data

Validated multidimensional questionnaire assessing recovery profile. Each scale is scored from 0-10, overall score from 0 to 150. The higher scores indicate better recovery.

Outcome measures

Outcome measures
Measure
TES 100 Hz DC:AC
n=15 Participants
Transcranial electrostimulation (TES) with combined direct (DC) and alternating (AC, 100 Hz) current
TES With DC Current
n=14 Participants
Transcranial electrostimulation (TES) with direct current (DC) only
TES 60 Hz DC:AC
n=14 Participants
Transcranial electrostimulation (TES) with combined direct (DC) and alternating (AC, 60 Hz) current
Change From Baseline in QoR15 Score (Quality of Recovery 15-question Score)
-31.0 score on a scale
Interval -60.0 to -25.0
-50.5 score on a scale
Interval -55.0 to -40.0
-36.5 score on a scale
Interval -58.25 to -19.75

Adverse Events

TES 60 Hz DC:AC

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

TES 100 Hz DC:AC

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

TES With DC Current

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Vladimir Nekhendzy, MD

Stanford University

Phone: (650) 723-6411

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place